Faculty Publications

Borghaei H, Ruth KJ, Tuttle H, Cohen R, Langer C, Simon G

Potential benefit with erlotinib (E) in patients with advanced non-small cell lung cancer (NSCLC) after first-line treatment with a cetuximab containing regimen (C)

Journal of Thoracic Oncology. 2009 Sep;4(9):S667-S667.

Abstract